Diabetes

Mazdutide, a dual glucagon and GLP-1 agonist, delivers greater HbA1c and weight reductions than dulaglutide in people with type 2 diabetes.

PUFA-rich and Nordic diets reduce liver fat and LDL cholesterol over 12 months, with broader metabolic benefits seen with the Nordic diet.

Global modelling study shows the economic burden of diabetes could reach trillions by 2050, with informal caregiving a major, under-recognised cost driver.

A 10-year hospital study reveals how often prediabetes progresses to type 2 diabetes, and how early intervention can reverse risk.

Meta-analysis shows diabetes increases male infertility risk, with inflammation identified as a key underlying mechanism.

Curcumin supplementation modestly lowers systolic blood pressure in adults with prediabetes and Type 2 diabetes.

A multi-species synbiotic supplement has led to measurable improvements in weight, metabolic control and cardiovascular risk markers in elderly people with type 2 diabetes.

NHANES data show glycaemic status and macronutrient intake are linked to sleep duration, sleep disorders, and sleep quality.